Skip to content

BIOTRICITY INC.

BTCY

CIK 0001630113

← back to feed
Revenue (TTM)
$15.37M
+14.3% YoY Q3 Feb 2026
Net Income (TTM)
−$3.31M
+40.3% YoY Q3 Feb 2026
EPS Diluted (TTM)
−$0.15
+66.6% YoY Q3 Feb 2026
Gross Margin
80.1%
Q3 Feb 2026
Operating Margin
5.4%
Q3 Feb 2026
Net Margin
-21.5%
Q3 Feb 2026
Free Cash Flow (TTM)
−$7.77M
Q3 Feb 2026
Cash
$256.36K
Q3 Feb 2026
Total Debt
$1.15M
Q3 Feb 2026
Shares Outstanding
28.44M sh
Q3 Feb 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings